Sotera Health Co's revenue was $1.16bn in fiscal 2025, up 5.7% on the year before. Since fiscal 2019 ($778m) it has grown at a compound 6.9% a year. Over the last twelve months it was $1.22bn.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to December 31, 2025
Sterigenics$756M
Nelson Labs$220M
Nordion$188M
Segments
Line of business
Revenue
Share
YoY
Sterigenics
$756M
65.0%
▲ 8.3%
Nelson Labs
$220M
18.9%
▼ 3.9%
Nordion
$188M
16.1%
▲ 8.2%
Services$996M
Products$168M
Products and services
Line of business
Revenue
Share
YoY
Services
$996M
85.6%
▲ 5.7%
Products
$168M
14.4%
▲ 5.8%
United States$630M
Europe$232M
Canada$222M
Other Geographical Areas$79.9M
Geography
Region
Revenue
Share
YoY
United States
$630M
54.1%
▲ 2.1%
Europe
$232M
20.0%
▲ 18.5%
Canada
$222M
19.1%
▲ 6.3%
Other Geographical Areas
$79.9M
6.9%
▲ 1.4%
From Sotera Health Co's 10-K filed February 24, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.
Figures from Sotera Health Co's SEC filings (10-K and 10-Q), retrieved October 20, 2026.
How we read and check them: methodology and data sources.
Not investment advice. Back to Sotera Health Co.
